Toggle navigation
Home
Search
Services
Blog
Contact
About
Mao/Assessment of Humoral Immune Responses (G)
Cosentino, Mark
Seracare Bioservices, Gaithersburg, MD, United States
Search 20 grants from Mark Cosentino
Search grants from Seracare Bioservices
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Income Inequality and Health: Does Race Matter?
Enzyme Thermistors as Glucose Sensors
Animal Diagnostic Laboratories
Comparative Clinical NMR Imaging Studies
Biomedical Research Support
Recently added grants:
Cancer Cell Biology Research Program
Immunology Research Program
Molecular Therapeutics Research Program
Virology Research Program
Cancer Genetics Research Program
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI055277-001
Application #
2296484
Study Section
Project Start
1995-09-30
Project End
1997-09-29
Budget Start
1996-06-07
Budget End
1997-09-29
Support Year
Fiscal Year
1996
Total Cost
Indirect Cost
Institution
Name
Seracare Bioservices
Department
Type
DUNS #
City
Gaithersburg
State
MD
Country
United States
Zip Code
20877
Related projects
NIH 1998
N01 AI
Mao/Assessment of Humoral Immune Responses (G)
Cosentino, Mark / Seracare Bioservices
NIH 1997
N01 AI
Mao/Assessment of Humoral Immune Responses (G)
Cosentino, Mark / Seracare Bioservices
NIH 1996
N01 AI
Mao/Assessment of Humoral Immune Responses (G)
Cosentino, Mark / Seracare Bioservices
NIH 1995
N01 AI
Mao/Assessment of Humoral Immune Responses (G)
Cosentino, Mark / Seracare Bioservices
Publications
Lillemeier, Björn F; Mörtelmaier, Manuel A; Forstner, Martin B et al.
(2010)
TCR and Lat are expressed on separate protein islands on T cell membranes and concatenate during activation.
Nat Immunol 11:90-6
Comments
Be the first to comment on Mark Cosentino's grant